TOPAS features its COC for medical device and diagnostic industry at MD&M West
TOPAS Advanced Polymers featured its line of cyclic olefin copolymers (COC) for the medical device and diagnostic industry at Medical Device and Manufacturing (MD&M) West 2014.
Most recently, TOPAS has launched TOPAS 5013L-10, an injection molding grade with an internal mold release which delivers balanced properties and easy processing. The new material delivers low birefringence and high molding accuracy (submicron detail replication) for optical parts for medical and diagnostic applications, said the company. The heat resistance and purity are suitable for DNA analysis, including typical 95°C PCR protocols.
The TOPAS COC family consists of amorphous, transparent copolymers based on cyclic and linear olefins. These materials can be customized by varying the chemical structure of the copolymer.
According to Timothy Kneale, President of TOPAS Advanced Polymers, it has found increasing usage in medical devices and diagnostic applications due to the materials' broad property profile.
As said, these biologically-inert materials offer high rigidity and dimensional stability; high purity with low extractables/leachables; good biocompatibility, chemical resistance, and moisture barrier; high UV transmission; and nice detail replication including submicron features. These materials also provide glass-like transparency, variable Tg and compatibility with all sterilization methods including steam, and compliance with USP Class VI/ISO 10993 and FDA regulations.
"We continue to focus our R&D efforts on new solutions that enable our medical customers to create next-generation products," says Mr Kneale,
Headquartered in Frankfurt, Germany, TOPAS Advanced Polymers is the joint venture of Daicel Corporation and Polyplastics, both from Japan.
MD&M West was held from February 10-13 in Anaheim, the US.
